---
title: "XtalPi Announces Strategic Senior Management Change"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270001148.md"
description: "XtalPi Holdings Limited announced a strategic senior management change as CFO Mr. Tam Man Hong transitions to Hong Kong and International Development Adviser in January 2026. This move aims to enhance the company's business development in Hong Kong and international markets, focusing on sustainable growth, mergers and acquisitions, and establishing an incubation ecosystem. The appointment of the next CFO will be announced later. This change is expected to strengthen XtalPi's regional and global presence."
datetime: "2025-12-17T11:08:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270001148.md)
  - [en](https://longbridge.com/en/news/270001148.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270001148.md)
---

# XtalPi Announces Strategic Senior Management Change

### Claim 50% Off TipRanks Premium and Invest with Confidence

-   Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

The latest update is out from QuantumPharm, Inc. ( (HK:2228) ).

XtalPi Holdings Limited has announced a change in senior management as CFO Mr. Tam Man Hong transitions to the role of Hong Kong and International Development Adviser effective January 2026. This strategic shift will allow Mr. Tam to focus on the company’s business development in Hong Kong and international markets, including contributing to sustainable growth, mergers and acquisitions, and establishing an incubation ecosystem. The announcement is positioned to strengthen XtalPi’s regional and global presence while ensuring consistent leadership guidance. Details regarding the appointment of the next CFO will be announced in due course.

The most recent analyst rating on (HK:2228) stock is a Hold with a HK$9.50 price target. To see the full list of analyst forecasts on QuantumPharm, Inc. stock, see the HK:2228 Stock Forecast page.

**More about QuantumPharm, Inc.**

XtalPi Holdings Limited operates within the pharmaceutical and biotechnological industry, providing innovative solutions that bridge artificial intelligence and molecular dynamics to accelerate drug discovery and development. The company and its subsidiaries focus on catering to international markets, encompassing cutting-edge technology and collaboration to enhance scientific advancement.

**Average Trading Volume:** 103,505,958

**Technical Sentiment Signal:** Hold

**Current Market Cap:** HK$39.27B

### Related Stocks

- [02228.HK](https://longbridge.com/en/quote/02228.HK.md)

## Related News & Research

- [Nvidia CEO says has capacity to supply robust CPU and GPU growth](https://longbridge.com/en/news/288346021.md)
- [SK Hynix plans to double wafer capacity in next five years, group chairman says](https://longbridge.com/en/news/288379830.md)
- [GDS Plans To Spend Up To 50B Yuan As AI Data Center Demand Booms](https://longbridge.com/en/news/288456977.md)
- [Xiaomi (XIACF): New Buy Recommendation for This Technology Giant](https://longbridge.com/en/news/288369028.md)
- [Xpeng initiates non-compete probe against former employees amid AI push](https://longbridge.com/en/news/288367459.md)